1.
Klekota J, Brauner E, Roth FP, Schreiber SL. Using high-throughput screening data to discriminate compounds with single-target effects from those with side effects. J Chem Inf Model. 2006;46(4):1549-62. doi:10.1021/ci050495h.
1.
Camacho DM, Collins KM, Powers RK, Costello JC, Collins JJ. Next-Generation Machine Learning for Biological Networks. Cell. 2018;173(7):1581-1592. doi:10.1016/j.cell.2018.05.015.
1.
Griveau A. [Treatment of the respiratory distress syndrome in newborns: smoothened agonist counterbalances deleterious effects of glucocorticoids]. Med Sci (Paris). 2012;28(2):141-3. doi:10.1051/medsci/2012282008.
1.
DeAngelo DJ, Neuberg D, Amrein PC, et al. A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia. Leuk Res. 2014;38(4):430-4. doi:10.1016/j.leukres.2013.10.026.
1.
Wagner BK, Kitami T, Gilbert TJ, et al. Large-scale chemical dissection of mitochondrial function. Nat Biotechnol. 2008;26(3):343-51. doi:10.1038/nbt1387.